Thépenier Pharma & Cosmetics

Name

Thépenier Pharma & Cosmetics

Legal name

Thepenier Pharma & Cosmetics

Website

https://thepenier-pharma.com

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical and Cosmetic Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical contract manufacturing
• Cosmetic OEM services
• CDMO services
• Skincare manufacturing
• GMP-compliant manufacturing

Headquarters

HQ city

Saint-langis-lès-mortagne

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing Services (CDMO/OEM-ODM): Full-service contract development and manufacturing organization serving pharmaceutical laboratories and cosmetic brands. Manages the complete supply chain from R&D formulation and regulatory support through industrial scale-up, manufacturing, packaging, quality control, and shipment. Revenue is generated through long-term manufacturing contracts and project-based development fees. Serves both pharma (drugs, OTC, medical devices) and cosmetics (skincare, personal care, makeup) segments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Thépenier Pharma & Cosmetics is a French Contract Development and Manufacturing Organization (CDMO) that develops and manufactures finished pharmaceutical, skincare, personal care, and make-up products for third-party brands. The company combines cosmetic formulation expertise with pharmaceutical-grade GMP manufacturing capabilities, offering clients full-service development from formulation to industrial-scale production.

Product overview

Thépenier Pharma & Cosmetics (TP&C) is a French CDMO/OEM contract manufacturer with over 60 years of experience, specializing in the development and manufacturing of pharmaceutical products, OTC medications, medical devices, skincare, personal care, hygiene, sun protection, and make-up products. The company operates as a full-service contract manufacturer offering a comprehensive portfolio that includes: Pharma Manufacturing Services (GMP-compliant production of dermatology, ENT, gastroenterology, oral care, and topical products), Skin Care Products (cleansers, moisturizers, serums, masks), Sun Protection (SPF 30/50+ mineral emulsions), Body and Hygiene Care, Make-up and Hybrid Beauty Products (including LashBloom Mascara and Wellness Booster Serum). The company is part of an international French-Japanese group (Nippon Shikizai Group) with 5 manufacturing plants across France and Japan, serving pharmaceutical labs and cosmetic brands with manufacturing capacities ranging from 1,500 to 10,000 liters for liquids, 1,000 to 5,000 liters for emulsions, and up to 500 kg for powder forms.

Differentiator

Problem solved

Functional benefit

Brands

• LashBloom Mascara: Eco-conscious mascara finalist at Cosmopack Awards 2025, with 99.7% naturally derived ingredients, COSMOS-compliant and vegan.
• Wellness Booster Serum

Products and services

• Pharmaceutical Manufacturing Services (CDMO) Contract development and manufacturing of pharmaceutical products, including formulation, regulatory support, and industrial production under pharmaceutical GMP standards. Targeted at pharmaceutical laboratories and healthcare brands requiring compliant manufacturing partners.
• Skincare Manufacturing Services Custom development and manufacturing of skincare products such as creams, serums, balms, and oils for cosmetics brands. Includes specialized product lines like Hybrid, Upcycling, Pre/Pro/Post-Biotics, and Hemp-based formulations.
• Make-up Manufacturing Services Custom development and manufacturing of make-up products including lipsticks, mascaras, foundations, powders, and other color cosmetics for beauty brands.
• Sun Protection Manufacturing Services Development and manufacturing of sun care and protection products, including sunscreens and after-sun products for cosmetic brands.
• Personal Care Manufacturing Services Development and manufacturing of personal care products such as body care items, including balms, oils, and hygiene products for consumer brands.
• LashBloom Mascara A self-fixing 24-hour lash and brow mascara product, part of Thépenier's make-up manufacturing portfolio.
• Wellness Booster Serum An active skincare serum product, part of the Wellness Booster range of skincare offerings.

Quantifiable outcome

• Non-quality defect rate consistently below 0.5% over 10 years
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered notable, supporting and core.

• Albéa GroupnotableStrategic or Co-development Partner · 1 July 2021Thépenier Pharma & Cosmetics and Albéa Group joined forces to offer manufacturing and filling solutions for Albéa's breakthrough paper-based tube 'Metamorphosis.' The tube requires delicate sealing expertise that TP&C's proven technical capabilities are uniquely suited to handle, serving Albéa's clients who prefer not to manage such sensitive filling operations. The Metamorphosis tube contains 45% less plastic than standard extruded tubes, reflecting shared commitment to sustainable solutions in both formula and packaging.
• TraceLinksupportingTechnology or IntegrationTP&C is associated with TraceLink to ensure complete alignment of serialization needs with various corresponding national regulations and to ensure harmonious distribution of pharmaceutical products. TraceLink provides digital supply chain traceability platform supporting regulatory compliance for serialization.
• Nippon Shikizai Inc.coreStrategic or Co-development PartnerNippon Shikizai Inc. is the parent company of Thépenier Pharma & Cosmetics, forming the Nippon Shikizai Group. This international group brings together French-Japanese DNA, with Nippon Shikizai operating 2 plants in Japan (makeup, skincare, emulsions) and TP&C operating 2 sites in Normandy, France (pharma, skincare, makeup, emulsions). The synergy provides access to J-Beauty expertise, clean beauty, hybrid beauty, and digi beauty know-how.
• Nippon Shikizai FrancecoreStrategic or Co-development PartnerSubsidiary of Thépenier Pharma & Cosmetics operating a manufacturing plant in Orléans for makeup powders, hot-poured, and scented products. Nippon Shikizai France specializes in mascara, eyeliner, and liquid foundation formulations, contributing the core makeup expertise to the Group. The subsidiary enables complete, hybrid, unique, and innovative makeup ranges combined with eco-responsible packaging.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Intercos: Italian-listed pure-play color cosmetics and skin-care contract manufacturer; most direct competitor to TP&C's Nippon Shikizai France subsidiary on mascara, eyeliner and liquid foundation manufacturing. Comparable in B2B beauty OEM-ODM model and European manufacturing footprint.
• Recipharm: European pharma CDMO (Swedish-headquartered) acquired by EQT-owned Asahi Group; comparable in offering small-molecule drug product contract manufacturing, serialization, and GMP-certified fill-finish, with deeper biologics exposure. Overlaps with TP&C on topical, oral, and sterile pharmaceutical manufacturing categories.
• Siegfried Holding: Swiss-listed pure-play pharma CDMO with global manufacturing footprint including France (Chauny). Overlaps with TP&C on small-molecule drug product manufacturing, GMP-certified contract services, and serialization; larger scale offers benchmark for valuation multiples in the European CDMO segment.
• PCI Pharma Services: Global pharma CDMO with strong GMP contract manufacturing, packaging, serialization and analytical services—categories that overlap directly with TP&C's services portfolio. Comparable in serving mid-market pharma and specialty brands requiring multi-market regulatory support.
• Aenova: German-headquartered CDMO specializing in solid oral, semi-solid and liquid pharmaceutical manufacturing for generics and OTCs; sister focus area is derma/cosmetics contract manufacturing. Closest European mid-market comparator on pharma+cosmetics CDMO with similar revenue band and similar GMP footprint.
• Fareva: French privately-held CDMO with pharma, cosmetics, and specialty manufacturing across multiple sites in Europe and emerging markets. Most direct comparable given shared French origin, multi-segment pharma/beauty OEM-ODM model, and similar size band; competes head-to-head on pharma contract manufacturing and dermo-cosmetics.
• Seqens (ICS Group): French specialty CDMO combining pharmaceutical ingredients, intermediates and finished dosage forms. Directly comparable on integrated drug substance + drug product model, French manufacturing base, and customer mix spanning generics, OTC and dermo-cosmetics.

Broad incumbents

• Lonza Group: Swiss global CDMO leader in API and drug product manufacturing including capsules and oral solids. Comparable in pharmaceutical CDMO service offering and European/Swiss GMP standards; larger scale and broader modality mix make it a strategic reference point rather than head-to-head competitor in cosmetics.
• Catalent: US-headquartered global CDMO leader (now Novo Holdings-owned). Overlaps with TP&C on softgel, oral and topical pharmaceutical contract manufacturing but operates at vastly larger scale across biologics, inhalation, and cell therapy; benchmark for scaling a mid-size CDMO into a global player.

Others

• Albea Group: Global beauty packaging manufacturer and existing TP&C partner on the Metamorphosis paper-tube filling project. Comparable as ecosystem participant in the clean/eco beauty value chain; complements rather than competes with TP&C's fill-finish CDMO services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/thepenier_labo
• LinkedInlinkedin.com/company/thepenier-pharma-cosmetics
• Instagraminstagram.com/thepenier_pharma_cosmetics

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Thépenier Pharma & Cosmetics